LungÕ 2026 – Virtual Global Congress on Lung Oncology
FDA Issues New Guidance on Cell and Gene Therapy Potency
L’OncoDaily Session at London Cancer Week 2026: Advancing the Global Conversation on Cancer Care
Tarlatamab: Mechanism, Neurotoxicity, and the Next Chapter in SCLC Treatment
Cancer Treatment Side Effects: A MedSafetyWeek 2026 Reminder
Financial Discrimination Against Cancer Survivors: Why the Right to Be Forgotten Is a Global Imperative
GDFATHER-NEO: Neoadjuvant Nivolumab + Visugromab in MIBC
Ciara Mageean, Olympic Runner and European Champion, Dies at 34 After Stage 4 Bowel Cancer
Hematology (OncoDaily Blood) is OncoDaily’s dedicated platform for hematologic oncology, covering the latest research, clinical advances and expert perspectives. Its coverage spans the major hematologic malignancies: acute and chronic leukemias, Hodgkin and non-Hodgkin lymphomas, multiple myeloma and other plasma cell disorders, myelodysplastic and myeloproliferative neoplasms. OncoDaily Blood follows advances in the understanding, diagnosis and treatment of blood cancers, with a focus on emerging strategies, targeted therapies, immunotherapies, CAR-T cell therapy, hematopoietic stem cell transplantation, and molecular and measurable residual disease testing. It reports on practice-changing clinical trials, major hematology congresses, treatment guidelines, regulatory approvals and real-world evidence.
